Clinical Trial

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

Name: Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic — clinical trial record (NCT07329907)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CA-SA/LA

Completed Phase 2

View on ClinicalTrials.gov →

Summary

Objective: To compare the efficacy, safety, and recurrence rates of topical salicylic acid/lactic acid (SA/LA) monotherapy (Group A), intralesional Candida antigen (CA) monotherapy (Group B), and their combination (Group C) for the treatment of warts.

Trial Details

NCT Number	NCT07329907
Lead Sponsor	Benha University
Conditions	Warts, Human Papilloma Virus (HPV)
Enrollment	126 participants
Start Date	2023-12-01
Primary Completion	2024-06-01 (estimated)
Study Completion	2024-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-04